|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0616 | ED148973 | General Research Use | No | Female | White | 77 | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 10 - Central GA |
| AR2_0711 | ED149421 | General Research Use | No | Female | White | 80 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1584 | ED148760 | General Research Use | No | Female | White | 59 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_2151 | ED149051 | General Research Use | No | Male | White | 78 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_2486 | ED149187 | General Research Use | No | Female | White | 76 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_2596 | ED148271 | General Research Use | No | Male | White | 62 | 9 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_2690 | ED148541 | General Research Use | No | Female | White | 65 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_2881 | ED148836 | General Research Use | No | Female | White | 78 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_3026 | ED149078 | General Research Use | No | Male | White | 56 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_3198 | ED148900 | General Research Use | No | Female | White | 72 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_3449 | ED148491 | General Research Use | No | Female | White | 62 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_3471 | ED148876 | General Research Use | No | Female | White | 74 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_4149 | ED148454 | General Research Use | No | Female | White | 72 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0185 | ED148387 | General Research Use | No | Female | White | 62 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_0506 | ED149124 | General Research Use | No | Male | White | 74 | 8 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0899 | ED148845 | General Research Use | No | Male | White | 75 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1032 | ED148211 | Eye Disease Only | No | Female | White | 76 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1501 | ED148394 | General Research Use | No | Female | White | 66 | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 10 - Central GA |
| AR2_3161 | ED148166 | General Research Use | No | Female | White | 74 | 7 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |
| AR2_3269 | ED149318 | General Research Use | No | Female | White | 80 | 8 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |